Summary
An adoptive immunotherapy of 6 patients with medulloblastoma by lymphokine-activated killer (LAK) cells is described. They were from 2 to 9 years in age and had cerebrospinal fluid (CSF) dissemination of the tumours. All patients underwent the whole-neuraxis irradiation and chemotherapy. After the usual treatments, they were submitted to an adoptive transfer of one-haplotype identical LAK cells. The LAK cells were induced from peripheral blood lymphocytes (PBL) of their relatives with human recombinant interleukin-2 (rIL-2). 3–15×109 LAK cells were transferred intrathecally in 2–3 months. In 3 of 6 patients, neurological signs were improved and malignant cells had never been detected on CSF cytology after the adoptive immunotherapy. One among these 3 patients showed complete response in 20 months. Thus, this is an attractive approach for the treatment of medulloblastoma with CSF dissemination of the tumour which current therapeutic intervention can not cure.
Similar content being viewed by others
References
Al-Mefty O, Jinkins JR, El-Senoussi M, El-Shaker M, Fox JL (1985) Medulloblastoma: a review of modern management with a reports on 75 cases. Surg Neurol 24: 606–624
Arseni C, Ciarea AD (1981) Statistical survey of 276 cases of medulloblastoma (1935–1978). Acta Neurochir (Wien) 57: 159–162
Baily P, Cushing H (1925) Medulloblastoma cerebelli. A common type of mid-cerebellar glioma of childhood. Arch Neurol Psychiat 14: 192–224
Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ (1981) Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 55: 43–51
Bloom HJG, Wallace EHK (1969) The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol 105: 43–62
Bloom HJG (1982) Medulloblastoma in children. Increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys 8: 2023–2027
Brightman MW, Klatzo I, Olsson Y (1970) The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 10: 215–239
Carrel S, de Tribolet N, Gross N (1982) Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol 12: 354–357
Chang CH, Hpusepian EH, Herbert C (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastoma. Radiology 93: 1351–1359
Chin HW, Maruyama Y (1984) Age at treatment and long-term performance results in medulloblastoma. Cancer 53: 1952–1958
Deutsch M, Reigel DH (1980) The value of myelography in the management of children medulloblastoma. Cancer 45: 2194–2197
Edwards MS, Levin VA, Seager ML, Wilson CB (1981) Intrathecal Chemotherapy for leptomeningeal dissemination of medulloblastoma. Childs Brain 8: 444–451
Farwell JR, Dohrmann GJ, Flannery JJ (1984) Medulloblastoma in children: An epidemiological study. J Neurosurg 61: 657–664
Friedman HS, Colvin OM, Ludeman SM, Schold SC, Boyd VL, Mulhbaier LH, Bingner DD (1986) Experimental chemotherapy of human medulloblastoma with classical alkylators. Cancer Res 46: 2827–2833
Leibel SA, Sheline GE (1987) Radiation therapy for neoplasms of the brain. J Neurosurg 66: 1–22
Levin VA, Vestnys PS, Edwards MS, Wara WM (1983) Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma. Cancer 51: 1364–1370
Mealey JJ, Hall PV (1977) Medulloblastoma in children: Survival and treatment. J Neurosurg 46: 56–64
Nishino S, Fukui M, Takeshita I, Nakagaki H, Kitamura K, Jingu K (1986) Recurrent medulloblastoma in children. Neurol Med Chir (Tokyo) 26: 19–25
Norris DG, Brace DA, Byrd RL, Schut L, Littman P, Bilaniuk LT, Zimmermann RA, Capp R (1981) Improved relapse-free survival in medulloblastoma utilizing modern techniques. Neurosurgery 9: 661–664
Okamoto Y, Shimizu K, Miyao Y (1986) The in vitro anti-tumor effectiveness of murine lymphokine-activated killer cells induced by recombinant IL-2. Brain Nerve 38: 233–237
Park TS, Hoffman HJ, Hendric EB, Humphreys RP (1983) Medulloblastoma: Clinical presentation and management. J Neurosurg 58: 543–552
Raimondi AJ, Tomita T (1979) Medulloblastoma in childhood. Comparative results of partial and total resection. Childs Brain 5: 310–328
Rosenberg SA, Lotze MT, Muul LM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485–1492
Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 137: 1735–1742
Rubinstein LJ (1975) The cerebellar medulloblastoma: Its origin, differentiation, morphological variants, and biological behavior. Handbook of clinical neurology, vol 18. North-Holland Pub Co. Amsterdam, Oxford, pp 167–193
Shapiro WR, Chernik NL, Posner JB (1973) Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol 28: 96–102
Shimizu K, Fujiwara H, Takatsu K (1983) Detection of antigenpresenting activity of HLA-DR positive glioma cell lines. 5th International Congress of Immunology, Kyoto
Shimizu K, Okamoto Y, Miyao Y (1985) Lysis of malignant gliomas by syngeneic murine splenocytes or autologous human peripheral blood lymphocytes activated in vitro with recombinant interleukin-2. J Neurol 232 (Suppl): 179
Shimizu K, Miyao Y, Okamoto Y (1986) The antitumor efficacy of lymphokine-activated killer cells induced in vitro from peripheral blood lymphocytes of patients with malignant gliomas. Brain Nerve 38: 265–271
Shimizu K, Okamoto Y, Miyao Y, Yamada M, Ushio Y, Hayakawa T, Ikeda H, Mogami H (1987) Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukin-2. J Neurosurg 66: 519–521
Smith CE, Long DM, Jones TK, Levitt SH (1973) Medulloblastoma: An analysis of time-dose relationship and recurrence patterns. Cancer 32: 722–728
Thomas PRM, Duffnere PK, Cohen ME, Sinks LF, Tebbi C, Freeman AI (1980) Multimodality therapy for medulloblastoma. Cancer 45: 666–669
Tomita T, McLone DG (1983) Spontaneous seeding of medulloblastoma: Results of cerebrospinal fluid cytology and arachnoid biopsy from the cisterna magna. Neurosurgery 12: 265–267
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okamoto, Y., Shimizu, K., Tamura, K. et al. An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK). Acta neurochir 94, 47–52 (1988). https://doi.org/10.1007/BF01406615
Issue Date:
DOI: https://doi.org/10.1007/BF01406615